ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

ORMP Oramed Pharmaceuticals Inc

2,29
-0,05 (-2,14%)
Zuletzt aktualisiert: 16:14:18
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
Oramed Pharmaceuticals Inc ORMP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,05 -2,14% 2,29 16:14:18
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
2,31 2,2505 2,34 2,34
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
19.3.202414:00GLOBEScilex Holding Company Announces Repayment in Full of the..
06.3.202423:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
20.2.202414:42EDGAR2Form 8-K - Current report
20.2.202414:30PRNUSOramed Letter to Shareholders
30.1.202423:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.1.202422:45EDGAR2Form 8-K - Current report
19.1.202422:45EDGAR2Form 8-K - Current report
08.1.202422:43EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08.1.202422:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02.1.202419:13EDGAR2Form 3 - Initial statement of beneficial ownership of..
21.12.202315:26EDGAR2Form 8-K - Current report
18.12.202322:45EDGAR2Form 8-K - Current report
09.11.202323:10EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
26.9.202322:34EDGAR2Form 8-K - Current report
22.9.202317:38PRNUSSorrento Therapeutics, Inc. Announces the Consummation of..
22.9.202300:11PRNUSOramed Announces $101,875,000 Short-Term Senior Secured Note..
21.9.202322:05GLOBEScilex Holding Company Announces the Consummation of the..
13.9.202315:00GLOBEScilex Holding Company Enters into Non-Binding Term Sheets..
13.9.202314:47EDGAR2Form 8-K - Current report
10.8.202323:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09.8.202314:30EDGAR2Form 8-K - Current report
07.8.202315:20EDGAR2Form 8-K - Current report
02.8.202313:45PRNUSOramed Signs Term Sheet with HTIT to Create a Joint Venture..
13.7.202323:00EDGAR2Form 8-K - Current report
20.6.202313:55PRNUSOramed to Present at the 83rd American Diabetes Association..
18.5.202313:55PRNUSOramed to Present at Novel Therapies for Type 2 Diabetes &..
15.5.202315:05PRNUSOramed Announces that its Chinese Partner, HTIT, has..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock